Ameraudi Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Ameraudi Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,747	Closed	-$457K	–	46
2025 Q4	$457K	Hold	3,747	–	–	0.25%	39
2025 Q3	$375K	Hold	3,747	–	–	0.23%	41
2025 Q2	$311K	Sell	3,747 -471	-11%	-$37.6K	0.16%	46
2025 Q1	$342K	Sell	4,218 -172	-4%	-$15.4K	0.2%	43
2024 Q4	$395K	Sell	4,390 -89	-2%	-$8.62K	0.22%	42
2024 Q3	$443K	Sell	4,479 -2,108	-32%	-$207K	0.2%	40
2024 Q2	$611K	Sell	6,587 -280	-4%	-$25.1K	0.28%	33
2024 Q1	$652K	Sell	6,867 -31,094	-82%	-$2.89M	0.3%	31
2023 Q4	$3.39M	Sell	37,961 -25,609	-40%	-$1.9M	1.49%	20
2023 Q3	$4.64M	Sell	63,570 -10,301	-14%	-$823K	2.21%	13
2023 Q2	$6.15M	Sell	73,871 -1,405	-2%	-$117K	2.69%	12
2023 Q1	$5.74M	Buy	75,276 +577	+0.8%	+$47.9K	2.5%	13
2022 Q4	$6.2M	Buy	74,699 +1,744	+2%	+$141K	2.67%	13
2022 Q3	$5.79M	Sell	72,955 -500	-0.7%	-$42.2K	2.6%	15
2022 Q2	$5.46M	Buy	+73,455	New	+$5.51M	2.25%	17

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Ameraudi Asset Management's XBI Position: Q1 2026 in Review

Ameraudi Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2026, closing a stake of 3,747 shares — an estimated $457K sold.

Ameraudi Asset Management first reported a position in XBI in Q2 2022 and held it in 15 quarters. The position peaked at $6.2M in Q4 2022. 816 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Ameraudi Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2026 after selling out during the quarter.
Ameraudi Asset Management sold 3,747 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $457K.
Ameraudi Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and held it in 15 quarters.
Ameraudi Asset Management's State Street SPDR S&P Biotech ETF position peaked at $6.2M in Q4 2022.
816 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Ameraudi Asset Management's 13F filing for Q1 2026, filed 15 May 2026.